| Strategies for Anticoagulation During Venovenous ECMO (NCT04997265) | Vanderbilt University Medical Center | 2022-05-12 |
| Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events (NCT05313620) | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | 2022-04-01 |
| Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement (NCT04258488) | Joon Bum Kim | 2022-02-21 |
| The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancer (NCT05178628) | Michalis Karamouzis | 2022-02-10 |
| The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKD (NCT05656963) | Yipeng Liu | 2021-09-01 |
| COVID-19 Pathophysiology of Long Term Implications (NCT04813575) | King Faisal Specialist Hospital & Research Center | 2021-08-01 |
| The Frequency of Peripheral Arterial Disease in Patients with Deep Vein Thrombosis of the Lower Limbs (NCT06806540) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2021-06-10 |
| Thromboprophylaxis in Oesophageal Cancer Patients (NCT05067153) | University of Aarhus | 2021-05-01 |
| Cellular-Mediated Immunity in COVID-19 (NCT04746521) | University of Campania Luigi Vanvitelli | 2021-03-14 |
| Pregnancy and Risk of Venous Thromboembolism (NCT03659708) | Hospices Civils de Lyon | 2021-01-22 |
| Endovascular thromBectomy of Acute Mesentery Vessels Occlusion Hybrid With Emergent Laparoscopic Surgery (NCT04686981) | Beijing Tsinghua Chang Gung Hospital | 2020-10-01 |
| Practice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19 (NCT04719182) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2020-09-01 |
| Lavare Cycle in Patients Receiving HeartWare Left Ventricular Assist Device (NCT04199793) | Vanderbilt University Medical Center | 2020-08-10 |
| Thromboembolic Risk Screening in Patients With Cancer and COVID-19 (NCT04616846) | Centre Antoine Lacassagne | 2020-08-04 |
| Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery (NCT04305756) | University of Utah | 2020-06-12 |
| Impact of an Intensified Thromboprofylaxis Protocol in COVID-19 (NCT04394000) | Jessa Hospital | 2020-05-04 |
| Influence of Cardiac Implantable Electronic Devices on the Hemostatic System (NCT04499612) | Ryazan State Medical University | 2020-03-01 |
| Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients (NCT04593654) | Karolinska Institutet | 2020-03-01 |
| Is Anti-Factor Xa Associated With Outcome in Patients With Critical COVID-19 on Low-Molecular-Weight Heparin? (NCT05256524) | Karolinska Institutet | 2020-03-01 |
| Biomarkers of Thrombosis as Predictors of Venous Thromboembolism Risk in Cancer Patients (NCT04301362) | Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. | 2019-07-19 |
| Apixaban in Adults With Congenital Heart Disease and Atrial Arrhythmias: the PROTECT-AR Study (NCT03854149) | AHEPA University Hospital | 2019-07-01 |
| Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic Therapy (NCT04072068) | Gruppo Oncologico Italiano di Ricerca Clinica | 2019-06-27 |
| Biomarkers of Acute Stroke in Clinic (NCT03897478) | Ischemia Care LLC | 2019-04-01 |
| Coagulation System In STereotactic Radiotherapy Of NSCLC (NCT03893461) | Odense University Hospital | 2019-03-26 |
| Prospective Evaluation of Efficacy and Safety of Fondaparinux in Surgical Cancer Patients, Risk Factors for Thromboembolism (NCT04246073) | Hellenic Society of Surgical Oncology | 2019-02-01 |
| Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms (NCT06065592) | Lebanese University | 2019-02-01 |
| Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE (NCT03581877) | Northwell Health | 2019-01-28 |
| Evaluation of ReX-C System in Measurement and Improvement of Patients' Adherence. (NCT03424330) | Dosentrx Ltd. | 2019-01-09 |
| PraxbindTM India PMS Program (NCT03359889) | Boehringer Ingelheim | 2018-12-26 |
| Registry of Thrombosis & NEoplasia of "Sociedad Española de Oncología Médica" (NCT03855592) | Fundación Sociedad Española de Oncologia Médica | 2018-07-04 |
| Tecarfarin Anti-Coagulation Trial (TACT) (NCT02522221) | Espero Biopharma | 2018-06-01 |
| Absorption of Rivaroxaban in Patients With Cervical Spinal Cord Injury (NCT02970773) | Swiss Paraplegic Research, Nottwil | 2017-12-04 |
| DVT After Cardiac Procedure (NCT03877770) | Manchester University NHS Foundation Trust | 2017-10-20 |
| Balancing of Patients Treated by Vitamin K Antagonists (VKAS) in General Medicine (NCT03914053) | University Hospital, Montpellier | 2017-07-01 |
| A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT) (NCT02913326) | Boehringer Ingelheim | 2016-12-13 |
| AMPLATZER™ LAA Occluder Post Approval Study (PAS) (NCT02964208) | Abbott Medical Devices | 2016-12-08 |
| Inflammatory Bowel Disease and Thromboembolic Events (NCT05162339) | Centro Hospitalar Tondela-Viseu | 2016-11-01 |
| Apixaban Discontinuation Prior to Major Surgery (NCT02935751) | Thomas Jefferson University | 2016-10-01 |
| Safety, Pharmacokinetics, Biodistribution, and Diagnostic Performance of [18F]GP1 PET in Thromboembolism (NCT02864810) | Asan Foundation | 2016-08-04 |
| Assessment of a Diagnostic Medical Device for the INR (International Normalized Ratio) Measurement (NCT02779400) | University Hospital, Grenoble | 2016-05-23 |
| Patient-Centered Anticoagulation Self-Monitoring in Minority Patients (NCT02776566) | University of Illinois at Chicago | 2016-01-01 |
| Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates (NCT02564718) | Bayer | 2015-11-19 |
| REVIparin-BRIDging-in a General Practice Setting in GErmany (NCT02579122) | Mylan Inc. | 2015-10-01 |
| Observational Study of Thrombogenic Properties in 220 Patients With Proximal Femur Fracture (NCT02475187) | Vestre Viken Hospital Trust | 2015-09-01 |
| LAAC-registry: Clinical Outcome After Echocardiography-guided LAA-closure (NCT04628078) | Insel Gruppe AG, University Hospital Bern | 2015-08-12 |
| Amplatzer™Amulet™ Post-Market Study (Amulet™PMS) (NCT02447081) | Abbott Medical Devices | 2015-06-01 |
| The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT (NCT02376803) | University of Alberta | 2015-02-01 |
| Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk (NCT02313584) | Korea University | 2014-12-01 |
| Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events (NCT02103101) | Centre Hospitalier Universitaire de Besancon | 2014-11-13 |
| Evaluation of the Risk of VTE Among Patients Hospitalized in Non-surgical Departments (NCT03073915) | Hadassah Medical Organization | 2013-08-01 |
| Prophylaxis of Venous Thromboembolism After Bariatric Surgery (NCT02295150) | Rijnstate Hospital | 2013-03-01 |
| Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder (NCT01707394) | Bristol-Myers Squibb | 2013-01-10 |
| Evaluation of Contrast Medium Enhanced Post-mortem CT in Virtual Autopsy (NCT01541995) | Universitätsklinikum Hamburg-Eppendorf | 2012-04-01 |
| Rivaroxaban in Endovenous Laser Ablation With and Without Miniphlebectomy (NCT02584842) | University Hospital, Basel, Switzerland | 2012-01-01 |
| Follow on Study From RE-ALIGN (NCT01505881) | Boehringer Ingelheim | 2011-12-01 |
| Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT (NCT01006733) | Washington University School of Medicine | 2011-03-01 |
| Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology (NCT01696760) | Ohio State University Comprehensive Cancer Center | 2010-10-01 |
| Subclinical Atherosclerosis Using Dual-source CT Coronary Angiography in Chinese Adults With Different Glycaemic Status (NCT01319201) | Shanghai Jiao Tong University School of Medicine | 2010-04-01 |
| Retrospective Study of Patients Who Were Treated With Fondaparinux Pre-, Peri- and/or Postpartum for Prophylaxis or Treatment of Venous Thromboembolism (NCT01004939) | GlaxoSmithKline | 2010-03-01 |
| Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement (NCT01094886) | Ortho-McNeil Janssen Scientific Affairs, LLC | 2010-03-01 |
| Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (NCT01006876) | Texas Cardiac Arrhythmia Research Foundation | 2010-01-01 |
| Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). (NCT00986154) | Daiichi Sankyo | 2009-10-01 |
| Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome (NCT01068795) | HaEmek Medical Center, Israel | 2009-07-01 |
| Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery (NCT00847301) | Boehringer Ingelheim | 2009-04-01 |
| Standard Diagnostic Procedures With or Without Fludeoxyglucose F 18 Positron Emission Tomography in Finding Cancer in Patients With a Blood Clot in a Vein (NCT00964275) | University Hospital, Brest | 2009-03-01 |
| Study to Evaluate the Safety and Efficacy of Pradaxar for the Prevention of Venous Thromboembolism in the Mexican Population Undergoing Elective Total Hip or Knee Replacement Surgery (NCT00967447) | Boehringer Ingelheim | 2009-02-01 |
| Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement Surgery (NCT00846807) | Boehringer Ingelheim | 2009-02-01 |
| Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy (NCT01132833) | UNC Lineberger Comprehensive Cancer Center | 2008-12-01 |
| SALTO - Epidemiological Study on Compliance and Treatment Satisfaction (NCT00911001) | Bayer | 2008-11-01 |
| Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin (NCT00927862) | Intermountain Health Care, Inc. | 2008-08-01 |
| A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty (NCT01203098) | Daiichi Sankyo Co., Ltd. | 2008-07-01 |
| Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE) (NCT00680186) | Boehringer Ingelheim | 2008-04-01 |
| Tapered Warfarin or Interrupted Warfarin With Heparin Bridging for Pacemaker or Defibrillator Implantation (NCT02094157) | McMaster University | 2007-12-01 |
| Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer (NCT00662688) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2007-10-01 |
| Special Drug Use Investigation for ARIXTRA® (Fondaparinux) Injection (NCT01420809) | GlaxoSmithKline | 2007-09-01 |
| Dalteparin in Preventing Blood Clots in Patients With Lung Cancer (NCT00519805) | Velindre NHS Trust | 2007-08-01 |
| The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings (NCT00830570) | Medco Health Solutions, Inc. | 2007-07-01 |
| Self-management of Low Molecular Weight Heparin Therapy (NCT00794560) | University Hospital, Basel, Switzerland | 2007-06-01 |
| A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation (NCT00504556) | Daiichi Sankyo | 2007-06-01 |
| Impact of Left Atrial Appendage Exclusion on Short-Term Clinical Outcomes and Long-Term Stroke Incidence (NCT00486915) | London Health Sciences Centre | 2007-04-01 |
| Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer (NCT00381888) | Masonic Cancer Center, University of Minnesota | 2007-01-01 |
| Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous Thromboembolism (NCT00423683) | Northwell Health | 2007-01-01 |
| Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement (NCT00408239) | Astellas Pharma Inc | 2006-12-01 |
| Thromboprophylaxis and Bariatric Surgery (NCT00444652) | University Hospital, Strasbourg, France | 2006-11-01 |
| Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors (NCT00433602) | European Organisation for Research and Treatment of Cancer - EORTC | 2006-11-01 |
| Institutional Registry of Thromboembolic Disease (NCT01372514) | Hospital Italiano de Buenos Aires | 2006-08-01 |
| Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus (NCT00371501) | Tuen Mun Hospital | 2006-06-01 |
| Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2) (NCT00353678) | Astellas Pharma Inc | 2006-06-01 |
| Secondary Prevention of Venous Thrombo Embolism (VTE). (NCT00329238) | Boehringer Ingelheim | 2006-05-01 |
| Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT) (NCT00375609) | Portola Pharmaceuticals | 2006-05-01 |
| Hip Fracture Study of GSK576428 (Fondaparinux Sodium) (NCT00320424) | GlaxoSmithKline | 2006-02-16 |
| Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism (NCT00291330) | Boehringer Ingelheim | 2006-02-01 |
| HTRS TE Registry (ThromboEmbolism Registry) (NCT00266994) | Nationwide Children's Hospital | 2005-12-01 |
| Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events (NCT00206089) | AstraZeneca | 2005-09-01 |
| Anticoagulant After Implantation of Biological Aortic Valve Comparing With Aspirin (NCT01452568) | Rigshospitalet, Denmark | 2005-06-01 |
| Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas (NCT00253669) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2005-04-01 |
| RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgery (NCT00168805) | Boehringer Ingelheim | 2004-11-01 |
| Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery (NCT00168818) | Boehringer Ingelheim | 2004-11-01 |
| Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery (NCT00096590) | National Cancer Institute (NCI) | 2004-11-01 |
| Safety Study of Stopping Thromboprophylaxis Based on Ultrasound Results After Total Knee Replacement (NCT00362492) | University Hospital, Caen | 2004-06-01 |